×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Report reflects good and bad of Paion's Cosmo deal
The Pharma Letter
Research firm Edison has raised its valuation of German specialty pharma company Paion but decreased the earnings per share (EPS) assessment...
94 months ago
Lundbeck Expands Rights to Paion's Vampire Bat Saliva Compounds for Stroke Therapy
Genetic Engineering and Biotechnology News
Desmoteplase is a plasminogen activator derived from a clot-dissolving protein found in the saliva of the vampire bat Desmodus rotundus. The...
162 months ago
This German Biotech had to stop its EU Phase III Trial for Lack of Recruitment
Labiotech.eu
Paion (Germany) has had to axe an EU phase III trial for a Surgical sedative after failing to recruit enough patients & will instead focus...
22 months ago
La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and ...
Business Wire
La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that...
39 months ago
It's time to Modernize Anesthetics! Meet the PAIONeers
Labiotech.eu
We travel from Finland back to the heart of Europe to visit the beautiful sights of Aachen, where we visit our Biotech of the week, Paion.
22 months ago
Mundipharma, Paion to develop remimazolam in Japan
The Malaysian Reserve
Mundipharma has entered into an exclusive licence agreement with Frankfurt-listed pharmaceutical company Paion AG.
76 months ago